UK Markets closed

Roche Holding AG (ROG.VX)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
266.50-0.10 (-0.04%)
At close: 5:30PM CEST
Interactive chart
Previous close266.60
Bid266.50 x 243000
Ask267.90 x 260500
Day's range265.40 - 267.70
52-week range218.30 - 273.00
Avg. volume1,690,503
Market cap226.47B
PE ratio (TTM)23.78
EPS (TTM)11.21
Earnings date27 Jul 2017
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Bloomberg12 days ago

    Roche Seeks to Mend Damaged Nerves in Multiple Sclerosis Push

    Roche Holding AG is seeking a partner with experimental drugs that might help repair the damage caused to the nervous system by multiple sclerosis -- considered a key step in managing the debilitating ...

  • Forbes18 days ago

    Human Antibody Discovery: Of Mice And Phage

    Human antibody discovery has come a long way in the last two decades, with contributions from transgenic mice and phage display. Author reviews the data on their success, speculates of why the former has outperformed, closing with thoughts on the future of antibody discovery

  • Roche Throws a New Wrinkle Into the IO Market
    Bloomberg19 days ago

    Roche Throws a New Wrinkle Into the IO Market

    Maybe this new breed of cancer drugs won't see skyrocketing sales growth.